Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 94

1.

Genome reorganization in different cancer types: detection of cancer specific breakpoint regions.

Standfuß C, Parczyk J, Ruhnau J, Klein A.

Mol Cytogenet. 2019 Jun 20;12:25. doi: 10.1186/s13039-019-0435-3. eCollection 2019.

2.

Scattering of spoof surface plasmon polaritons in defect-rich THz waveguides.

Klein AK, Basden A, Hammler J, Tyas L, Cooke M, Balocco C, Zeze D, Girkin JM, Gallant A.

Sci Rep. 2019 Apr 18;9(1):6288. doi: 10.1038/s41598-019-42412-6.

3.

BRCA1 and Breast Cancer: a Review of the Underlying Mechanisms Resulting in the Tissue-Specific Tumorigenesis in Mutation Carriers.

Semmler L, Reiter-Brennan C, Klein A.

J Breast Cancer. 2019 Jan 22;22(1):1-14. doi: 10.4048/jbc.2019.22.e6. eCollection 2019 Mar. Review.

4.

The structure of CgnJ, a domain of unknown function protein from the crocagin gene cluster.

Adam S, Klein A, Surup F, Koehnke J.

Acta Crystallogr F Struct Biol Commun. 2019 Mar 1;75(Pt 3):205-211. doi: 10.1107/S2053230X19000712. Epub 2019 Feb 21.

PMID:
30839296
5.

The energy level of the Fe2+/3+-transition in BaTiO3 and SrTiO3 single crystals.

Suzuki I, Gura L, Klein A.

Phys Chem Chem Phys. 2019 Mar 13;21(11):6238-6246. doi: 10.1039/c8cp07872f.

PMID:
30834394
6.

Multi-Level Cell Properties of a Bilayer Cu₂O/Al₂O₃ Resistive Switching Device.

Deuermeier J, Kiazadeh A, Klein A, Martins R, Fortunato E.

Nanomaterials (Basel). 2019 Feb 19;9(2). pii: E289. doi: 10.3390/nano9020289.

7.

The effects of 2-hydroxyglutarate on the tumorigenesis of gliomas.

Reiter-Brennan C, Semmler L, Klein A.

Contemp Oncol (Pozn). 2018;22(4):215-222. doi: 10.5114/wo.2018.82642. Epub 2018 Dec 31. Review.

8.

Analysis of the interfacial characteristics of BiVO4/metal oxide heterostructures and its implication on their junction properties.

Hermans Y, Murcia-López S, Klein A, van de Krol R, Andreu T, Morante JR, Toupance T, Jaegermann W.

Phys Chem Chem Phys. 2019 Feb 27;21(9):5086-5096. doi: 10.1039/c8cp07483f.

PMID:
30762849
9.

Survival Outcomes of Younger Patients With Mantle Cell Lymphoma Treated in the Rituximab Era.

Gerson JN, Handorf E, Villa D, Gerrie AS, Chapani P, Li S, Medeiros LJ, Wang MI, Cohen JB, Calzada O, Churnetski MC, Hill BT, Sawalha Y, Hernandez-Ilizaliturri FJ, Kothari S, Vose JM, Bast MA, Fenske TS, Narayana Rao Gari S, Maddocks KJ, Bond D, Bachanova V, Kolla B, Chavez J, Shah B, Lansigan F, Burns TF, Donovan AM, Wagner-Johnston N, Messmer M, Mehta A, Anderson JK, Reddy N, Kovach AE, Landsburg DJ, Glenn M, Inwards DJ, Karmali R, Kaplan JB, Caimi PF, Rajguru S, Evens A, Klein A, Umyarova E, Pulluri B, Amengual JE, Lue JK, Diefenbach C, Fisher RI, Barta SK.

J Clin Oncol. 2019 Feb 20;37(6):471-480. doi: 10.1200/JCO.18.00690. Epub 2019 Jan 7.

PMID:
30615550
10.

Role of soluble inflammatory mediators and different immune cell populations in early control of symptomatic acute hepatitis C virus infection.

Hengst J, Klein AL, Lunemann S, Deterding K, Hardtke S, Falk CS, Manns MP, Cornberg M, Schlaphoff V, Wedemeyer H.

J Viral Hepat. 2019 Apr;26(4):466-475. doi: 10.1111/jvh.13050. Epub 2019 Feb 1.

PMID:
30548086
11.

Author Correction: Limitation of Fermi level shifts by polaron defect states in hematite photoelectrodes.

Lohaus C, Klein A, Jaegermann W.

Nat Commun. 2018 Nov 12;9(1):4794. doi: 10.1038/s41467-018-07410-8.

12.

Daratumumab binds to mobilized CD34+ cells of myeloma patients in vitro without cytotoxicity or impaired progenitor cell growth.

Ma X, Wong SW, Zhou P, Chaulagain CP, Doshi P, Klein AK, Sprague K, Kugelmass A, Toskic D, Warner M, Miller KB, Lee L, Varga C, Comenzo RL.

Exp Hematol Oncol. 2018 Oct 16;7:27. doi: 10.1186/s40164-018-0119-4. eCollection 2018.

13.

Limitation of Fermi level shifts by polaron defect states in hematite photoelectrodes.

Lohaus C, Klein A, Jaegermann W.

Nat Commun. 2018 Oct 17;9(1):4309. doi: 10.1038/s41467-018-06838-2. Erratum in: Nat Commun. 2018 Nov 12;9(1):4794.

14.

Multicenter Phase II Study of Sequential Brentuximab Vedotin and Doxorubicin, Vinblastine, and Dacarbazine Chemotherapy for Older Patients With Untreated Classical Hodgkin Lymphoma.

Evens AM, Advani RH, Helenowski IB, Fanale M, Smith SM, Jovanovic BD, Bociek GR, Klein AK, Winter JN, Gordon LI, Hamlin PA.

J Clin Oncol. 2018 Oct 20;36(30):3015-3022. doi: 10.1200/JCO.2018.79.0139. Epub 2018 Sep 4.

PMID:
30179569
15.

Clinicopathologic characteristics of secondary squamous cell carcinoma of head and neck in survivors of allogeneic hematopoietic stem cell transplantation for hematologic malignancies.

Chaulagain CP, Sprague KA, Pilichowska M, Cowan J, Klein AK, Kaul E, Miller KB.

Bone Marrow Transplant. 2019 Apr;54(4):560-566. doi: 10.1038/s41409-018-0299-x. Epub 2018 Aug 20.

PMID:
30127467
16.

Inositol-C2-PAF acts as a biological response modifier and antagonizes cancer-relevant processes in mammary carcinoma cells.

Pelz C, Häckel S, Semini G, Schrötter S, Bintig W, Stricker S, Mrawietz G, Klein A, Lucka L, Shmanai V, Eickholt B, Hildmann A, Danker K.

Cell Oncol (Dordr). 2018 Oct;41(5):505-516. doi: 10.1007/s13402-018-0387-3. Epub 2018 Jul 25.

PMID:
30047091
17.

Natural biocide cocktails: Combinatorial antibiotic effects of prodigiosin and biosurfactants.

Hage-Hülsmann J, Grünberger A, Thies S, Santiago-Schübel B, Klein AS, Pietruszka J, Binder D, Hilgers F, Domröse A, Drepper T, Kohlheyer D, Jaeger KE, Loeschcke A.

PLoS One. 2018 Jul 19;13(7):e0200940. doi: 10.1371/journal.pone.0200940. eCollection 2018.

18.

Assessment of a shortened informed consent form for pediatric research: a pilot study.

Murray PD, Bierer BE, Hirschfeld S, Klein AK, Davis JM.

Pediatr Res. 2018 Oct;84(4):516-519. doi: 10.1038/s41390-018-0043-7. Epub 2018 May 18.

PMID:
29967521
19.

Preparation of Cyclic Prodiginines by Mutasynthesis in Pseudomonas putida KT2440.

Klein AS, Brass HUC, Klebl DP, Classen T, Loeschcke A, Drepper T, Sievers S, Jaeger KE, Pietruszka J.

Chembiochem. 2018 May 2. doi: 10.1002/cbic.201800154. [Epub ahead of print]

PMID:
29719131
20.

Autologous transplantation versus allogeneic transplantation in patients with follicular lymphoma experiencing early treatment failure.

Smith SM, Godfrey J, Ahn KW, DiGilio A, Ahmed S, Agrawal V, Bachanova V, Bacher U, Bashey A, Bolaños-Meade J, Cairo M, Chen A, Chhabra S, Copelan E, Dahi PB, Aljurf M, Farooq U, Ganguly S, Hertzberg M, Holmberg L, Inwards D, Kanate AS, Karmali R, Kenkre VP, Kharfan-Dabaja MA, Klein A, Lazarus HM, Mei M, Mussetti A, Nishihori T, Ramakrishnan Geethakumari P, Saad A, Savani BN, Schouten HC, Shah N, Urbano-Ispizua A, Vij R, Vose J, Sureda A, Hamadani M.

Cancer. 2018 Jun 15;124(12):2541-2551. doi: 10.1002/cncr.31374. Epub 2018 Apr 12.

Supplemental Content

Loading ...
Support Center